BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14510692)

  • 1. Hepatic insulin gene therapy in insulin-dependent diabetes mellitus.
    Nett PC; Sollinger HW; Alam T
    Am J Transplant; 2003 Oct; 3(10):1197-203. PubMed ID: 14510692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for type 1 diabetes. New approaches.
    Morral N
    Minerva Med; 2004 Apr; 95(2):93-104. PubMed ID: 15272244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering of insulin expression in nonislet cells: implications for beta-cell replacement therapy for insulin-dependent diabetes mellitus.
    Lipes MA; Davalli AM; Cooper EM
    Acta Diabetol; 1997 Mar; 34(1):2-5. PubMed ID: 9134049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
    Prasad KM; Yang Z; Bleich D; Nadler JL
    Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy.
    Ren B; O'Brien BA; Byrne MR; Ch'ng E; Gatt PN; Swan MA; Nassif NT; Wei MQ; Gijsbers R; Debyser Z; Simpson AM
    J Gene Med; 2013 Jan; 15(1):28-41. PubMed ID: 23293075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for beta-cell functional replacement in IDDM.
    Falqui L
    J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():789-93. PubMed ID: 10626271
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.
    Johnson JH; Crider BP; McCorkle K; Alford M; Unger RH
    N Engl J Med; 1990 Mar; 322(10):653-9. PubMed ID: 2406597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.
    Li R; Buras E; Lee J; Liu R; Liu V; Espiritu C; Ozer K; Thompson B; Nally L; Yuan G; Oka K; Chang B; Samson S; Yechoor V; Chan L
    Gene Ther; 2015 Nov; 22(11):876-82. PubMed ID: 26172077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting autoimmune diabetes with gene therapy.
    Giannoukakis N; Rudert WA; Robbins PD; Trucco M
    Diabetes; 1999 Nov; 48(11):2107-21. PubMed ID: 10535443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.
    Sapir T; Shternhall K; Meivar-Levy I; Blumenfeld T; Cohen H; Skutelsky E; Eventov-Friedman S; Barshack I; Goldberg I; Pri-Chen S; Ben-Dor L; Polak-Charcon S; Karasik A; Shimon I; Mor E; Ferber S
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7964-9. PubMed ID: 15899968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in insulin gene therapy for type 1 diabetes.
    Yoon JW; Jun HS
    Trends Mol Med; 2002 Feb; 8(2):62-8. PubMed ID: 11815271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for diabetes.
    Demeterco C; Levine F
    Front Biosci; 2001 Feb; 6():D175-91. PubMed ID: 11171547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene- and cell-based therapy of diabetes: between bench and bedside.
    Kofman AV; Kharazova AD; Pinaev GP
    Tsitologiia; 2002; 44(12):1157-77. PubMed ID: 12683326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue.
    Lee HC; Kim SJ; Kim KS; Shin HC; Yoon JW
    Nature; 2000 Nov; 408(6811):483-8. PubMed ID: 11100731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
    Strandell E; Sandler S
    J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction.
    Elsner M; Terbish T; Jörns A; Naujok O; Wedekind D; Hedrich HJ; Lenzen S
    Mol Ther; 2012 May; 20(5):918-26. PubMed ID: 22354377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I.
    Giannoukakis N; Mi Z; Rudert WA; Gambotto A; Trucco M; Robbins P
    Gene Ther; 2000 Dec; 7(23):2015-22. PubMed ID: 11175313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin gene therapy for type 1 diabetes mellitus.
    Handorf AM; Sollinger HW; Alam T
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():37-45. PubMed ID: 25894126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.